CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis
Clinical trial NCT01325194 · COMPLETED
Trial details
- NCT number
- NCT01325194
- Sponsor
- Nordic Lymphoma Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2018-11-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.